Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The West Nile virus envelope glycoprotein E is a major surface glycoprotein responsible for mediating viral attachment and entry into host cells. It facilitates membrane fusion, a crucial step for viral infection, through conformational changes triggered by low pH. The E protein is a key target for neutralizing antibodies and potential therapeutic interventions. It consists of three domains (I, II, and III), with domain II containing the fusion loop essential for membrane fusion and domain III thought to contain the receptor binding site. Glycosylation of the E protein is important for the virus's neuroinvasiveness and transmission by mosquitoes.
Neutralization of viral entry by targeting the E protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on West Nile virus envelope glycoprotein E (None).